Cite Filings / SABS / 0001437749-23-015192

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

SAB Biotherapeutics, Inc. Filed 2023-05-19 Acc 0001437749-23-015192

Documents 1

DEF 14A Proxy Statement , sabs20230516_def14a.htm

Around this filing

2023-10-30 DEF 14A Proxy Statement
2023-05-19 DEF 14A Proxy Statement
2023-05-17 EFFECT Notice of Effectiveness
2023-05-15 10-Q Quarterly Report
2023-05-15 CORRESP Correspondence Between Filers and SEC Staff
2023-05-12 8-K Regulation FD disclosure
2022-05-25 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading sabs20230516_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…